Verastem (VSTM) EBT (2011 - 2026)

Verastem's EBT history runs 16 years deep, the most recent figure standing at -$44.5 million for Q1 2026.

• On a quarterly basis, EBT changed 0.11% year-over-year to -$44.5 million in Q1 2026; TTM through Mar 2026 was -$183.5 million, a 39.04% decrease from a year earlier, with the FY2025 full-year figure at -$209.5 million, down 60.57% from the prior year.
• EBT fell to -$44.5 million in Q1 2026 per VSTM's latest filing, from -$40.8 million in the prior quarter.
• Across five years, EBT topped out at -$16.8 million in Q4 2022 and bottomed at -$54.0 million in Q2 2025.
• The 5-year median for EBT is -$29.6 million (2023), against an average of -$30.0 million.
• Across the five-year window, EBT jumped 36.87% in 2022 and plunged 192.7% in 2025, its largest moves.
• Year by year, EBT stood at -$16.8 million in 2022, then plunged by 76.25% to -$29.6 million in 2023, then slipped by 7.28% to -$31.8 million in 2024, then dropped by 28.39% to -$40.8 million in 2025, then slipped by 9.0% to -$44.5 million in 2026.
• Per Business Quant, the three latest VSTM EBT figures stand at -$44.5 million (Q1 2026), -$40.8 million (Q4 2025), and -$44.3 million (Q3 2025).